title: Systematic exploration of the structural features of yatakemycin impacting DNA alkylation and biological activity.
abstract: A systematic examination of the impact of the yatakemycin left and right subunits and their substituents is detailed along with a study of its unique three subunit arrangement (sandwiched vs extended and reversed analogues). The examination of the ca. 50 analogues prepared illustrate that within the yatakemycin three subunit structure, the subunit substituents are relatively unimportant and that it is the unique sandwiched arrangement that substantially increases the rate and optimizes the efficiency of its DNA alkylation reaction. This potentiates the cytotoxic activity of yatakemycin and its analogues overcoming limitations typically observed with more traditional compounds in the series (CC-1065, duocarmycins). Moreover, a study of the placement of the alkylation subunit within the three subunit arrangement (sandwiched vs extended and reversed analogues) indicates that it not only has a profound impact on the rate and efficiency of DNA alkylation but also controls and establishes the DNA alkylation selectivity as well, where both enantiomers of such sandwiched agents alkylate the same adenine sites exhibiting the same DNA alkylation selectivity independent of their absolute configuration.
authors: Department of Chemistry and the Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
authors: Mark S
authors: MS
authors: Tichenor
authors: Karen S
authors: KS
authors: MacMillan
authors: John D
authors: JD
authors: Trzupek
authors: Thomas J
authors: TJ
authors: Rayl
authors: Inkyu
authors: I
authors: Hwang
authors: Dale L
authors: DL
authors: Boger
mesh_terms: D000478:Alkylation / Q000187:drug effects; D000903:Antibiotics, Antineoplastic / Q000737:chemistry* / Q000494:pharmacology; D004247:DNA / Q000737:chemistry* / Q000378:metabolism; D000080890:Duocarmycins; D007211:Indoles / Q000737:chemistry* / Q000494:pharmacology; D008958:Models, Molecular; D011758:Pyrroles / Q000737:chemistry* / Q000494:pharmacology; D013329:Structure-Activity Relationship
chemical_list: D000903:Antibiotics, Antineoplastic; D000080890:Duocarmycins; D007211:Indoles; D011758:Pyrroles; C474180:yatakemycin; D004247:DNA
references: Chem Rev. 1997 May 8;97(3):787-828
references: 11848889
references: Chem Rev. 2002 Jul;102(7):2477-95
references: 12105933
references: J Antibiot (Tokyo). 2003 Feb;56(2):107-13
references: 12715869
references: Bioorg Med Chem. 2003 Aug 15;11(17):3815-38
references: 12901927
references: J Am Chem Soc. 2003 Sep 10;125(36):10971-6
references: 12952479
references: J Am Chem Soc. 2004 Jan 14;126(1):80-1
references: 14709069
references: J Am Chem Soc. 2004 Jul 14;126(27):8396-8
references: 15237994
references: Chem Biol. 2004 Dec;11(12):1607-17
references: 15610844
references: Nat Chem Biol. 2006 Feb;2(2):79-82
references: 16415862
references: J Am Chem Soc. 2006 Jun 7;128(22):7136-7
references: 16734447
references: J Am Chem Soc. 2006 Dec 13;128(49):15683-96
references: 17147378
references: Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1431-5
references: 1847523
references: J Antibiot (Tokyo). 1990 Aug;43(8):1037-8
references: 2211354
references: Chem Biol Interact. 1990;73(1):29-52
references: 2406033
references: Tetrahedron. 1991;47(14-15):2661-82
references: 30260354
references: J Antibiot (Tokyo). 1988 Dec;41(12):1915-7
references: 3209484
references: J Med Chem. 1988 Mar;31(3):590-603
references: 3346875
references: Biochemistry. 1988 May 17;27(10):3886-92
references: 3408734
references: J Antibiot (Tokyo). 1981 Sep;34(9):1119-25
references: 7328053
references: Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3642-9
references: 7731958
references: Bioorg Med Chem. 1994 Feb;2(2):115-35
references: 7922122
references: Bioorg Med Chem. 1995 Nov;3(11):1429-53
references: 8634824
references: Bioorg Med Chem. 1997 Feb;5(2):263-76
references: 9061191